Which of the following medications—Depakote (valproic acid), temazepam, and ziprasidone—does not cause hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Temazepam and ziprasidone do not cause hyponatremia; Depakote (valproic acid) does.

Among these three medications, temazepam and ziprasidone are not associated with causing hyponatremia, while Depakote (valproic acid) is a well-established cause of hyponatremia and SIADH.

Depakote (Valproic Acid) - CAUSES Hyponatremia

Valproic acid is clearly documented as causing hyponatremia through SIADH (syndrome of inappropriate antidiuretic hormone secretion). Multiple guidelines and research studies confirm this association:

  • Guideline evidence: The 2015 Endocrine Society guidelines explicitly list valproic acid among antiepileptic drugs (AEDs) associated with weight gain and metabolic complications 1
  • Mechanism: Valproic acid likely causes reduced sensitivity of hypothalamic osmoreceptors and may directly affect tubular cell function, leading to SIADH 2
  • Clinical significance: Case reports document severe symptomatic hyponatremia with sodium levels as low as 99 mEq/L following valproic acid use 3. A case/non-case analysis from Vigibase showed a corrected reporting odds ratio of 1.83 (95% CI 1.61-2.08) for the association between valproic acid and hyponatremia 2
  • Risk profile: Among antiseizure medications, carbamazepine and oxcarbazepine carry the highest risk, but valproic acid remains a significant contributor 4, 5, 6

Ziprasidone - Does NOT Typically Cause Hyponatremia

Ziprasidone is notably weight-neutral and lacks the metabolic side effects seen with other antipsychotics:

  • FDA label: The official ziprasidone drug label does not list hyponatremia as a recognized adverse effect 7
  • Guideline evidence: The 2015 Endocrine Society guidelines specifically note that ziprasidone produces minimal weight gain (only 7% of patients gained >7% body weight, compared to 30% with olanzapine) and is associated with less metabolic disturbance than other antipsychotics 1
  • Isolated case report: Only one case report exists of hyponatremia with ziprasidone, but this occurred in combination with duloxetine (an SSRI known to cause SIADH), making causality unclear 8

Temazepam - Does NOT Cause Hyponatremia

Benzodiazepines, including temazepam, are not associated with hyponatremia:

  • No guideline or drug label evidence links temazepam to hyponatremia
  • Benzodiazepines do not affect sodium homeostasis or antidiuretic hormone secretion
  • When benzodiazepines appear in hyponatremia studies, they are identified as risk factors only when used concomitantly with other causative agents (like carbamazepine or antipsychotics) 6

Clinical Monitoring Recommendations

For patients on valproic acid:

  • Check serum sodium at baseline and periodically during treatment, especially in the first month 9
  • Monitor more closely in elderly patients, those on diuretics, or those taking multiple medications that affect sodium 6
  • Consider dose-related effects—higher doses may increase risk 2
  • Watch for symptoms: lethargy, confusion, nausea, headache (chronic hyponatremia) or delirium, seizures (acute hyponatremia) 5

For patients on ziprasidone or temazepam:

  • Routine sodium monitoring is not required based on these medications alone
  • If hyponatremia develops, investigate other causes first

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.